HEADER BLOOD CLOTTING 06-AUG-19 6Q1U TITLE STRUCTURE OF PLASMIN AND PEPTIDE COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMINOGEN; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.4.21.7; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: GLY-ARG-ALA-TYR-LYS-SER-LYS-PRO-PRO-ILE-ALA-PHE-PRO-ASP; COMPND 8 CHAIN: C, D; COMPND 9 ENGINEERED: YES; COMPND 10 OTHER_DETAILS: WHM IS A TRIAZOLE MOTIF THAT REPLACES THE DISULPHIDE COMPND 11 BOND SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PLG; SOURCE 6 EXPRESSION_SYSTEM: KOMAGATAELLA PHAFFII GS115; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 644223; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HELIANTHUS ANNUUS; SOURCE 11 ORGANISM_TAXID: 4232 KEYWDS SERINE PROTEASE, CYCLIC PEPTIDE, COMPLEX, ANTIFIBRINOLYSIS, BLOOD KEYWDS 2 CLOTTING EXPDTA X-RAY DIFFRACTION AUTHOR G.WU,R.H.P.LAW REVDAT 4 11-OCT-23 6Q1U 1 LINK REVDAT 3 15-JUL-20 6Q1U 1 JRNL REVDAT 2 22-APR-20 6Q1U 1 JRNL REVDAT 1 15-APR-20 6Q1U 0 JRNL AUTH A.M.WHITE,S.J.DE VEER,G.WU,P.J.HARVEY,K.YAP,G.J.KING, JRNL AUTH 2 J.E.SWEDBERG,C.K.WANG,R.H.P.LAW,T.DUREK,D.J.CRAIK JRNL TITL APPLICATION AND STRUCTURAL ANALYSIS OF TRIAZOLE-BRIDGED JRNL TITL 2 DISULFIDE MIMETICS IN CYCLIC PEPTIDES. JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 59 11273 2020 JRNL REFN ESSN 1521-3773 JRNL PMID 32270580 JRNL DOI 10.1002/ANIE.202003435 REMARK 2 REMARK 2 RESOLUTION. 2.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.16_3549 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.69 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 22557 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.235 REMARK 3 R VALUE (WORKING SET) : 0.233 REMARK 3 FREE R VALUE : 0.287 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.400 REMARK 3 FREE R VALUE TEST SET COUNT : 993 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.6800 - 4.4900 0.98 3206 143 0.2029 0.2056 REMARK 3 2 4.4900 - 3.5600 0.99 3089 180 0.1910 0.2607 REMARK 3 3 3.5600 - 3.1100 0.99 3106 88 0.2240 0.2897 REMARK 3 4 3.1100 - 2.8300 0.99 3046 166 0.2507 0.3204 REMARK 3 5 2.8300 - 2.6300 0.99 3065 135 0.2640 0.3204 REMARK 3 6 2.6300 - 2.4700 1.00 3019 165 0.2914 0.3898 REMARK 3 7 2.4704 - 2.3500 0.98 3033 116 0.3045 0.3905 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.354 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 33.633 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.72 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.37 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 4037 REMARK 3 ANGLE : 0.702 5504 REMARK 3 CHIRALITY : 0.051 608 REMARK 3 PLANARITY : 0.005 729 REMARK 3 DIHEDRAL : 16.583 2428 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6Q1U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-AUG-19. REMARK 100 THE DEPOSITION ID IS D_1000243481. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-DEC-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4-6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.953732013702 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22667 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.347 REMARK 200 RESOLUTION RANGE LOW (A) : 46.691 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.18900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.43 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.71400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6D3X REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM SODIUM CITRATE, 100 MM MGCL2, REMARK 280 18% PEG 4000, PH 5.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 39.61400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.59900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.14650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 41.59900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 39.61400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.14650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1210 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10760 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1220 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 543 REMARK 465 PRO A 544 REMARK 465 SER A 545 REMARK 465 GLY A 560 REMARK 465 ARG A 561 REMARK 465 ALA B 543 REMARK 465 PRO B 544 REMARK 465 SER B 545 REMARK 465 GLY B 560 REMARK 465 ARG B 561 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 557 CG CD CE NZ REMARK 470 ARG A 582 CD NE CZ NH1 NH2 REMARK 470 LYS A 607 CG CD CE NZ REMARK 470 ASN A 625 CG OD1 ND2 REMARK 470 GLU A 627 CG CD OE1 OE2 REMARK 470 ARG A 677 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 708 CD CE NZ REMARK 470 GLU A 749 CG CD OE1 OE2 REMARK 470 LYS A 750 CG CD CE NZ REMARK 470 LYS B 557 CG CD CE NZ REMARK 470 LYS B 607 CG CD CE NZ REMARK 470 ASN B 625 CG OD1 ND2 REMARK 470 GLU B 627 CG CD OE1 OE2 REMARK 470 ARG B 677 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 708 CD CE NZ REMARK 470 GLU B 749 CG CD OE1 OE2 REMARK 470 LYS B 750 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 624 -72.46 -108.14 REMARK 500 THR A 659 -169.57 -124.03 REMARK 500 ARG A 677 17.51 87.24 REMARK 500 PHE A 692 164.96 68.44 REMARK 500 PHE A 715 -107.66 -109.22 REMARK 500 LYS A 750 -80.77 63.32 REMARK 500 SER A 760 -73.41 -128.60 REMARK 500 VAL B 624 -67.26 -99.03 REMARK 500 PHE B 692 158.02 66.68 REMARK 500 PHE B 715 -99.30 -113.09 REMARK 500 LYS B 750 -81.06 57.82 REMARK 500 ASP B 751 16.71 -142.29 REMARK 500 SER B 760 -68.67 -128.27 REMARK 500 ASN B 769 17.82 58.58 REMARK 500 LYS C 5 39.44 -95.68 REMARK 500 LYS D 5 46.64 -92.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide WMH C 101 and ALA C REMARK 800 3 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide WMH C 101 and ALA C REMARK 800 11 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide WMH D 101 and ALA D REMARK 800 11 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide WMH D 101 and ALA D REMARK 800 3 DBREF 6Q1U A 543 791 UNP P00747 PLMN_HUMAN 562 810 DBREF 6Q1U B 543 791 UNP P00747 PLMN_HUMAN 562 810 DBREF 6Q1U C 1 14 PDB 6Q1U 6Q1U 1 14 DBREF 6Q1U D 1 14 PDB 6Q1U 6Q1U 1 14 SEQRES 1 A 249 ALA PRO SER PHE ASP CYS GLY LYS PRO GLN VAL GLU PRO SEQRES 2 A 249 LYS LYS CYS PRO GLY ARG VAL VAL GLY GLY CYS VAL ALA SEQRES 3 A 249 HIS PRO HIS SER TRP PRO TRP GLN VAL SER LEU ARG THR SEQRES 4 A 249 ARG PHE GLY MET HIS PHE CYS GLY GLY THR LEU ILE SER SEQRES 5 A 249 PRO GLU TRP VAL LEU THR ALA ALA HIS CYS LEU GLU LYS SEQRES 6 A 249 SER PRO ARG PRO SER SER TYR LYS VAL ILE LEU GLY ALA SEQRES 7 A 249 HIS GLN GLU VAL ASN LEU GLU PRO HIS VAL GLN GLU ILE SEQRES 8 A 249 GLU VAL SER ARG LEU PHE LEU GLU PRO THR ARG LYS ASP SEQRES 9 A 249 ILE ALA LEU LEU LYS LEU SER SER PRO ALA VAL ILE THR SEQRES 10 A 249 ASP LYS VAL ILE PRO ALA CYS LEU PRO SER PRO ASN TYR SEQRES 11 A 249 VAL VAL ALA ASP ARG THR GLU CYS PHE ILE THR GLY TRP SEQRES 12 A 249 GLY GLU THR GLN GLY THR PHE GLY ALA GLY LEU LEU LYS SEQRES 13 A 249 GLU ALA GLN LEU PRO VAL ILE GLU ASN LYS VAL CYS ASN SEQRES 14 A 249 ARG TYR GLU PHE LEU ASN GLY ARG VAL GLN SER THR GLU SEQRES 15 A 249 LEU CYS ALA GLY HIS LEU ALA GLY GLY THR ASP SER CYS SEQRES 16 A 249 GLN GLY ASP SER GLY GLY PRO LEU VAL CYS PHE GLU LYS SEQRES 17 A 249 ASP LYS TYR ILE LEU GLN GLY VAL THR SER TRP GLY LEU SEQRES 18 A 249 GLY CYS ALA ARG PRO ASN LYS PRO GLY VAL TYR VAL ARG SEQRES 19 A 249 VAL SER ARG PHE VAL THR TRP ILE GLU GLY VAL MET ARG SEQRES 20 A 249 ASN ASN SEQRES 1 B 249 ALA PRO SER PHE ASP CYS GLY LYS PRO GLN VAL GLU PRO SEQRES 2 B 249 LYS LYS CYS PRO GLY ARG VAL VAL GLY GLY CYS VAL ALA SEQRES 3 B 249 HIS PRO HIS SER TRP PRO TRP GLN VAL SER LEU ARG THR SEQRES 4 B 249 ARG PHE GLY MET HIS PHE CYS GLY GLY THR LEU ILE SER SEQRES 5 B 249 PRO GLU TRP VAL LEU THR ALA ALA HIS CYS LEU GLU LYS SEQRES 6 B 249 SER PRO ARG PRO SER SER TYR LYS VAL ILE LEU GLY ALA SEQRES 7 B 249 HIS GLN GLU VAL ASN LEU GLU PRO HIS VAL GLN GLU ILE SEQRES 8 B 249 GLU VAL SER ARG LEU PHE LEU GLU PRO THR ARG LYS ASP SEQRES 9 B 249 ILE ALA LEU LEU LYS LEU SER SER PRO ALA VAL ILE THR SEQRES 10 B 249 ASP LYS VAL ILE PRO ALA CYS LEU PRO SER PRO ASN TYR SEQRES 11 B 249 VAL VAL ALA ASP ARG THR GLU CYS PHE ILE THR GLY TRP SEQRES 12 B 249 GLY GLU THR GLN GLY THR PHE GLY ALA GLY LEU LEU LYS SEQRES 13 B 249 GLU ALA GLN LEU PRO VAL ILE GLU ASN LYS VAL CYS ASN SEQRES 14 B 249 ARG TYR GLU PHE LEU ASN GLY ARG VAL GLN SER THR GLU SEQRES 15 B 249 LEU CYS ALA GLY HIS LEU ALA GLY GLY THR ASP SER CYS SEQRES 16 B 249 GLN GLY ASP SER GLY GLY PRO LEU VAL CYS PHE GLU LYS SEQRES 17 B 249 ASP LYS TYR ILE LEU GLN GLY VAL THR SER TRP GLY LEU SEQRES 18 B 249 GLY CYS ALA ARG PRO ASN LYS PRO GLY VAL TYR VAL ARG SEQRES 19 B 249 VAL SER ARG PHE VAL THR TRP ILE GLU GLY VAL MET ARG SEQRES 20 B 249 ASN ASN SEQRES 1 C 14 GLY ARG ALA TYR LYS SER LYS PRO PRO ILE ALA PHE PRO SEQRES 2 C 14 ASP SEQRES 1 D 14 GLY ARG ALA TYR LYS SER LYS PRO PRO ILE ALA PHE PRO SEQRES 2 D 14 ASP HET WMH C 101 6 HET WMH D 101 6 HETNAM WMH 1-METHYL-1H-1,2,3-TRIAZOLE FORMUL 5 WMH 2(C3 H5 N3) FORMUL 7 HOH *172(H2 O) HELIX 1 AA1 ALA A 601 GLU A 606 5 6 HELIX 2 AA2 ARG A 610 SER A 612 5 3 HELIX 3 AA3 GLU A 706 ASN A 711 1 6 HELIX 4 AA4 PHE A 780 ASN A 791 1 12 HELIX 5 AA5 ALA B 601 GLU B 606 5 6 HELIX 6 AA6 ARG B 610 SER B 613 5 4 HELIX 7 AA7 GLU B 706 ASN B 711 1 6 HELIX 8 AA8 PHE B 780 ASN B 791 1 12 SHEET 1 AA1 7 CYS A 566 VAL A 567 0 SHEET 2 AA1 7 LYS A 698 ILE A 705 -1 O GLU A 699 N CYS A 566 SHEET 3 AA1 7 GLU A 679 GLY A 684 -1 N CYS A 680 O LEU A 702 SHEET 4 AA1 7 PRO A 744 GLU A 749 -1 O VAL A 746 N PHE A 681 SHEET 5 AA1 7 LYS A 752 GLY A 762 -1 O LYS A 752 N GLU A 749 SHEET 6 AA1 7 ALA C 3 TYR C 4 -1 O ALA C 3 N GLY A 762 SHEET 7 AA1 7 ILE C 10 ALA C 11 -1 O ILE C 10 N TYR C 4 SHEET 1 AA2 7 CYS A 566 VAL A 567 0 SHEET 2 AA2 7 LYS A 698 ILE A 705 -1 O GLU A 699 N CYS A 566 SHEET 3 AA2 7 GLU A 724 ALA A 727 -1 O CYS A 726 N ILE A 705 SHEET 4 AA2 7 GLY A 772 ARG A 776 -1 O TYR A 774 N LEU A 725 SHEET 5 AA2 7 LYS A 752 GLY A 762 -1 N TRP A 761 O VAL A 773 SHEET 6 AA2 7 ALA C 3 TYR C 4 -1 O ALA C 3 N GLY A 762 SHEET 7 AA2 7 ILE C 10 ALA C 11 -1 O ILE C 10 N TYR C 4 SHEET 1 AA3 7 GLN A 576 THR A 581 0 SHEET 2 AA3 7 HIS A 586 SER A 594 -1 O GLY A 590 N VAL A 577 SHEET 3 AA3 7 TRP A 597 THR A 600 -1 O LEU A 599 N THR A 591 SHEET 4 AA3 7 ALA A 648 LEU A 652 -1 O LEU A 650 N VAL A 598 SHEET 5 AA3 7 GLN A 631 LEU A 640 -1 N SER A 636 O LYS A 651 SHEET 6 AA3 7 TYR A 614 LEU A 618 -1 N VAL A 616 O ILE A 633 SHEET 7 AA3 7 GLN A 576 THR A 581 -1 N SER A 578 O ILE A 617 SHEET 1 AA4 7 CYS B 566 VAL B 567 0 SHEET 2 AA4 7 LYS B 698 ILE B 705 -1 O GLU B 699 N CYS B 566 SHEET 3 AA4 7 GLU B 679 GLY B 684 -1 N CYS B 680 O LEU B 702 SHEET 4 AA4 7 PRO B 744 GLU B 749 -1 O VAL B 746 N PHE B 681 SHEET 5 AA4 7 LYS B 752 GLY B 762 -1 O LYS B 752 N GLU B 749 SHEET 6 AA4 7 ALA D 3 TYR D 4 -1 O ALA D 3 N GLY B 762 SHEET 7 AA4 7 ILE D 10 ALA D 11 -1 O ILE D 10 N TYR D 4 SHEET 1 AA5 7 CYS B 566 VAL B 567 0 SHEET 2 AA5 7 LYS B 698 ILE B 705 -1 O GLU B 699 N CYS B 566 SHEET 3 AA5 7 GLU B 724 ALA B 727 -1 O CYS B 726 N ILE B 705 SHEET 4 AA5 7 GLY B 772 ARG B 776 -1 O TYR B 774 N LEU B 725 SHEET 5 AA5 7 LYS B 752 GLY B 762 -1 N TRP B 761 O VAL B 773 SHEET 6 AA5 7 ALA D 3 TYR D 4 -1 O ALA D 3 N GLY B 762 SHEET 7 AA5 7 ILE D 10 ALA D 11 -1 O ILE D 10 N TYR D 4 SHEET 1 AA6 7 GLN B 576 ARG B 580 0 SHEET 2 AA6 7 HIS B 586 LEU B 592 -1 O CYS B 588 N LEU B 579 SHEET 3 AA6 7 TRP B 597 THR B 600 -1 O LEU B 599 N THR B 591 SHEET 4 AA6 7 ALA B 648 LEU B 652 -1 O LEU B 650 N VAL B 598 SHEET 5 AA6 7 GLN B 631 LEU B 640 -1 N SER B 636 O LYS B 651 SHEET 6 AA6 7 LYS B 615 LEU B 618 -1 N VAL B 616 O ILE B 633 SHEET 7 AA6 7 GLN B 576 ARG B 580 -1 N ARG B 580 O LYS B 615 SSBOND 1 CYS A 548 CYS A 666 1555 1555 2.05 SSBOND 2 CYS A 558 CYS A 566 1555 1555 2.04 SSBOND 3 CYS A 588 CYS A 604 1555 1555 2.04 SSBOND 4 CYS A 680 CYS A 747 1555 1555 2.04 SSBOND 5 CYS A 710 CYS A 726 1555 1555 2.03 SSBOND 6 CYS A 737 CYS A 765 1555 1555 2.05 SSBOND 7 CYS B 548 CYS B 666 1555 1555 2.05 SSBOND 8 CYS B 558 CYS B 566 1555 1555 2.04 SSBOND 9 CYS B 588 CYS B 604 1555 1555 2.03 SSBOND 10 CYS B 680 CYS B 747 1555 1555 2.04 SSBOND 11 CYS B 710 CYS B 726 1555 1555 2.03 SSBOND 12 CYS B 737 CYS B 765 1555 1555 2.05 LINK N GLY C 1 C ASP C 14 1555 1555 1.33 LINK CB ALA C 3 C WMH C 101 1555 1555 1.50 LINK CB ALA C 11 C1 WMH C 101 1555 1555 1.50 LINK N GLY D 1 C ASP D 14 1555 1555 1.33 LINK CB ALA D 3 C WMH D 101 1555 1555 1.50 LINK CB ALA D 11 C1 WMH D 101 1555 1555 1.50 CISPEP 1 LYS C 7 PRO C 8 0 -7.46 CISPEP 2 LYS D 7 PRO D 8 0 -5.06 SITE 1 AC1 8 TRP A 761 GLY A 762 GLY C 1 ARG C 2 SITE 2 AC1 8 TYR C 4 PRO C 9 ILE C 10 ALA C 11 SITE 1 AC2 5 ARG C 2 ALA C 3 PRO C 9 ILE C 10 SITE 2 AC2 5 PHE C 12 SITE 1 AC3 6 ARG D 2 ALA D 3 PRO D 9 ILE D 10 SITE 2 AC3 6 PHE D 12 HOH D 204 SITE 1 AC4 9 TRP B 761 GLY B 762 GLY D 1 ARG D 2 SITE 2 AC4 9 TYR D 4 LYS D 5 PRO D 9 ILE D 10 SITE 3 AC4 9 ALA D 11 CRYST1 79.228 80.293 83.198 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012622 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012454 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012020 0.00000